Effectiveness and safety of damoctocog alfa pegol in patients with hemophilia a with a history of factor viii inhibitors: interim analysis from the real-world hem-powr study
G. Castaman,M. T. Reding,Alvarez M. T. Roman,M. Janbain,F. Peyvandi,T. Matsushita,K. Meijer,K. Schmidt,J. Oldenburg
